Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Karyopherin subunit alpha 3 (KPNA3), commonly known as importin alpha-3, is a nuclear transport protein belonging to the importin alpha family, functioning as an adapter that recognizes nuclear localization signals (NLSs) on cargo proteins[2]. It forms a complex with importin beta (KPNB1), facilitating the translocation of large proteins through the nuclear pore complex in a Ran-dependent GTPase cycle[2]. KPNA3 is critically involved in the nuclear import of various proteins, including those implicated in neurodegenerative diseases. In the context of spinocerebellar ataxia type 3 (SCA3), KPNA3 mediates the import of polyglutamine-expanded ataxin-3, promoting its nuclear aggregation and toxicity, which are central to disease pathogenesis[1]. Experimental inhibition or knockdown of KPNA3 has been shown to rescue neurodegenerative phenotypes in in vivo models, highlighting its significance as a therapeutic target for disorders characterized by abnormal nuclear import and protein aggregation[1]. KPNA3 may play roles in infectious disease pathways and other disorders involving nucleocytoplasmic transport.
Inhibition or modulation of KPNA3 can reduce abnormal nuclear import of disease-related proteins such as ataxin-3, alleviating toxicity and aggregation implicated in neurodegenerative diseases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Karyopherin subunit alpha 3 (KPNA3).